Method for detecting multiple components of heat-clearing and detoxifying oral liquid by using UPLC-MS

The UPLC-MS method detects various components in the oral liquid of clearing heat and detoxifying, which solves the problems of low detection efficiency and insufficient accuracy in the prior art, and realizes efficient and accurate multi-component detection, ensuring the stability of product quality and security.

CN118961927APending Publication Date: 2024-11-15HENAN QUANYU PHARMA CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411060771.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art has insufficient quality control under the complexity of the composition of traditional Chinese medicine compound preparations, the effect of clearing heat and detoxifying oral liquid, and the multi-target and multi-level effects, and traditional methods have low detection efficiency and insufficient accuracy, making it difficult to fully control product quality.

Method used

UPLC-MS method was used to detect malic acid, chlorogenic acid, gallic acid, gentilic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid, salicylic acid in oral liquid The content of the content can be achieved through ultra-high performance liquid chromatography combined with mass spectrometry technology to achieve simultaneous detection and accurate quantification of multi-components.

Benefits of technology

It improves detection efficiency and accuracy, enhances detection sensitivity, reduces detection time and cost, and ensures product quality stability and clinical medication safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118961927A_ABST
    Figure CN118961927A_ABST
Patent Text Reader

Abstract

The invention discloses a method for detecting multiple components of a heat-clearing and detoxifying oral liquid by using UPLC-MS, and relates to the technical field of traditional Chinese medicine preparation analysis. Determining the contents of malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid and salicylic acid in the preparation by adopting an ultra-high performance liquid chromatography-mass spectrometry; comprising the following steps: preparing a test solution, namely precisely measuring 1mL of oral liquid for clearing away heat and toxic materials, putting the oral liquid into a 10mL volumetric flask, fixing the volume to a scale by using pure water, uniformly shaking and filtering to obtain the test solution; preparation of a reference substance solution: precisely weighing reference substances of malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid and salicylic acid, and placing the reference substances in a volumetric flask; according to the invention, multiple components can be detected at the same time, and the detection efficiency is greatly improved; and misjudgment caused by inaccurate detection of a single component is avoided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicine preparation analysis, and in particular to a method for detecting multiple components of a heat-clearing and detoxifying oral liquid by using UPLC-MS. Background Art

[0002] Qingrejiedu oral liquid is a traditional Chinese medicine preparation, mainly used to treat fever, thirst, dry throat, sore throat and other symptoms caused by heat toxins. Qingrejiedu oral liquid is a traditional Chinese medicine prescription composed of 12 traditional Chinese medicines: gypsum, honeysuckle, Scrophularia, Rehmannia, Forsythia, Gardenia, Sweet Herba Lycoris, Scutellaria, Gentiana, Isatis, Anemarrhena, and Ophiopogon. It is mainly used for fever, red face, irritability, thirst, sore throat caused by excessive heat toxins; influenza and upper respiratory tract infection with the above symptoms.

[0003] At present, the current inspection items for heat-clearing and detoxifying preparations in the 2020 edition of the Chinese Pharmacopoeia mainly include thin-layer identification of chlorogenic acid, gardenia glycosides, forsythia glycosides, smilax glabra sapogenin, and ophiopogon japonicus, as well as high-performance liquid chromatography to determine the content of baicalin. Traditional Chinese medicine compound preparations have complex ingredients, multiple targets, and multiple levels of action. The above quality control measures alone are not enough to fully control the quality of heat-clearing and detoxifying oral liquids.

[0004] Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS) is a high-resolution, high-sensitivity analytical technique that combines ultra-high performance liquid chromatography (UPLC) and mass spectrometry (MS) to separate and identify compounds in complex mixtures. It has the advantages of high resolution, high sensitivity, and rapid analysis. The present invention discloses a UPLC-MS method for simultaneous detection of multiple components of Qingrejiedu Oral Liquid, which achieves precise quantification and control of 10 components in the preparation, thereby ensuring the stability of product quality and the safety and effectiveness of clinical medication, and also provides data reference for improving the quality standard of Qingrejiedu Oral Liquid.

[0005] After searching, the application scheme of Chinese patent application No. 202111271069.4 discloses a method for detecting the Bu Shen Tian Jing oral liquid, including thin layer chromatography to identify the active ingredients of Astragalus, Ginseng, Epimedium, Lycium barbarum, Angelica and Heishun Tablets in Bu Shen Tian Jing oral liquid, and high performance liquid chromatography to identify the active ingredients of Cistanche deserticola. The detection method in the above patent has the following shortcomings: thin layer chromatography and high performance liquid chromatography are used to identify and determine the active ingredients, the operation steps are relatively cumbersome, and the detection efficiency and accuracy are still insufficient. Summary of the invention

[0006] The purpose of the present invention is to solve the shortcomings of the prior art and to propose a method for detecting multiple components of Qingrejiedu oral liquid by using UPLC-MS.

[0007] In order to achieve the above object, the present invention adopts the following technical solutions:

[0008] A method for detecting multiple components of a Qingrejiedu oral liquid by using UPLC-MS, wherein the method uses ultra-high performance liquid chromatography coupled with mass spectrometry to determine the contents of malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid, and salicylic acid in the preparation;

[0009] The following steps are involved:

[0010] S1: Preparation of test solution: accurately measure 1 mL of Qingrejiedu oral solution, place it in a 10 mL volumetric flask, dilute to the mark with pure water, shake well, filter, and use as the test solution;

[0011] S2: Preparation of reference solution: accurately weigh malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid, and salicylic acid reference substances, place in a volumetric flask, add methanol and pure water to dissolve and dilute to the mark, shake well to obtain;

[0012] S3: Determine the HPLC-MS conditions: UPLC chromatographic conditions: C18 chromatographic column, 0.1% formic acid aqueous solution as mobile phase A, methanol as mobile phase B, gradient elution;

[0013] S4: Determination method: Accurately pipette 1.5 mL of reference solution and test solution into injection bottles respectively, place in ultra-high performance liquid chromatography, and determine according to the chromatographic conditions described in S3.

[0014] Preferably: in S2, weigh malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid, and salicylic acid reference substances, place them in a volumetric flask, add 50% methanol to dissolve and dilute to the scale, and shake well.

[0015] Preferably, in the S2, 50%-90% methanol and pure water are added in a ratio of 50:50 to dissolve and dilute to the scale, and shake well to obtain.

[0016] Preferably: in S3, the specification of the chromatographic column is 2.1×100 mm, and the particle size is 1.8 μm.

[0017] Preferably: in S3, the detection wavelength is 230-250 nm; the flow rate is 0.2-0.4 mL / min; and the column temperature is 20-40°C.

[0018] Preferably: in S3, the gradient elution condition is:

[0019]

[0020]

[0021] Preferably: the mass spectrometry conditions of the method are as follows:

[0022]

[0023] Preferably: in S3, the detection wavelength is 240 nm, the flow rate is 0.3 mL / min, and the column temperature is 20°C.

[0024] Preferably: in said S3, Agilent 1290 liquid phase + G6470 tandem mass spectrometer is specifically used.

[0025] The beneficial effects of the present invention are:

[0026] 1. The present invention improves the detection efficiency. The traditional detection method can usually only detect a few components in the heat-clearing and detoxifying oral liquid, while the multi-component detection method of the present invention can detect multiple components at the same time, greatly improving the detection efficiency.

[0027] 2. The present invention improves detection accuracy. The multi-component detection method can detect multiple components at the same time, avoiding misjudgment caused by inaccurate detection of a single component.

[0028] 3. The present invention can detect trace components in the heat-clearing and detoxifying oral liquid through a multi-component detection method, thereby improving the sensitivity of detection.

[0029] 4. The multi-component detection method of the present invention can detect multiple components simultaneously, reducing the time and cost required for detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 This is the total ion current diagram of the mixed solution of the Qingrejiedu oral liquid reference substance;

[0031] Figure 2 This is the total ion current diagram of the Qingrejiedu oral liquid sample of Henan Quanyu Pharmaceutical Co., Ltd.

[0032] Figure 3 This is the total ion current diagram of the Qingrejiedu oral liquid sample from Wuhan Taifu Pharmaceutical Co., Ltd.

[0033] Figure 4 This is the total ion current diagram of the Qingrejiedu oral liquid sample of Furen Pharmaceutical Group Co., Ltd.

[0034] Figure 5 This is the total ion current diagram of the Qingrejiedu oral liquid sample produced by Henan Centennial Kangxin Pharmaceutical Co., Ltd.

[0035] Figure 6 This is the total ion current diagram of the Qingrejiedu oral liquid sample of Sunflower Pharmaceutical Biopharmaceutical Co., Ltd.

[0036] Figure 7 This is the total ion current diagram of the Qingrejiedu oral liquid sample produced by Beijing Tongrentang Technology Development Co., Ltd. DETAILED DESCRIPTION

[0037] The technical solution of the present invention is further described in detail below in conjunction with specific implementation methods.

[0038] Embodiment 1:

[0039] Study on the UPLC-MS Determination Methodology of 10 Components in Qingrejiedu Oral Liquid

[0040] 1 Materials

[0041] 1.1 Instruments: Agilent 1290 liquid phase + G6470 tandem mass spectrometer, electronic balance (14D101-1000), KQ-100 ultrasonic cleaning machine (Kunshan Ultrasonic Instrument Co., Ltd.).

[0042] 1.2 Reagents: Malic acid (lot number: P5010539), chlorogenic acid (lot number: P5010694), gallic acid (lot number: P5012548), gentisic acid (lot number: P5231130-12), cinnamic acid (lot number: P5000799), isochlorogenic acid C (lot number: P5001057), isochlorogenic acid A (lot number: P5001052), caffeic acid (lot number: P5010522), salicylic acid (lot number: P5001250), citric acid (lot number: P5020654)

[0043] The reference substance was purchased from Chengdu Pusi Biotechnology Co., Ltd. Methanol was from Merck (chromatographic grade), water was ultrapure water, and other reagents were of analytical grade.

[0044] 1.3 Test drug: 10 batches of Qingrejiedu oral liquid were provided by Henan Quanyu Pharmaceutical Co., Ltd. The sample batch numbers are shown in Table 1. After inspection, they all meet the requirements of Qingrejiedu oral liquid in the 2020 edition of the Chinese Pharmacopoeia.

[0045] Table 1 Sample batch number of Qingrejiedu oral liquid

[0046]

[0047] 2 Chromatographic conditions

[0048] Chromatographic column: ZORBAX RRHD C18 column, 2.1×100 mm, particle size 1.8 μm; 0.1% formic acid water as mobile phase A, methanol as mobile phase B, detection wavelength: 240 nm; flow rate: 0.3 mL / min; column temperature: 20°C; gradient elution according to the following table:

[0049]

[0050]

[0051] 4. Investigation of content determination methodology

[0052] 4.1 Preparation of test solution

[0053] Accurately measure 1 mL of Qingrejiedu oral liquid, place it in a 10 mL volumetric flask, dilute to the mark with ultrapure water, shake well, filter, and use as the test solution;

[0054] 4.2 Preparation of mixed reference solution

[0055] Accurately weigh appropriate amounts of malic acid, chlorogenic acid, gallic acid, and gentisic acid reference substances, and add ultrapure water to make them contain 2.20 mg, 2.40 mg, 2.50 mg, and 2.50 mg per 5 mL; accurately weigh appropriate amounts of cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, salicylic acid, and citric acid reference substances, and add 50% methanol to make them contain 2.80 mg, 2.50 mg, 2.30 mg, 2.50 mg, 2.70 mg, and 2.50 mg per 5 mL.

[0056] 4.3 Investigation of linear relationship

[0057] Accurately weigh an appropriate amount of reference substance, add 70% methanol to make the following concentrations, and perform the determination under the above chromatographic conditions, inject 2 μL of each sample, and determine the peak area. The results are shown in Table 2.

[0058] Table 2 Results of linear relationship investigation of 12 components

[0059]

[0060]

[0061]

[0062] For malic acid determination, the peak area was used as the ordinate and the concentration of the reference substance (μg / mL) was used as the abscissa to draw a standard curve, and the regression equation was y=2498.410526x-12379.540734, R 2 =0.99997, that is, the linearity of malic acid concentration is good in the range of 20.834-82.334 μg / mL.

[0063] Chlorogenic acid determination, with the measured peak area as the ordinate and the reference substance concentration (μg / mL) as the abscissa, the standard curve was drawn and the regression equation was y=1307.482378x+6835.364537, R 2 =0.99992, that is, the linearity of chlorogenic acid concentration was good in the range of 20-80 μg / mL.

[0064] Gallic acid determination, with the peak area as the ordinate and the reference substance concentration (μg / mL) as the abscissa, draw a standard curve and get the regression equation y=2237.034403x+

[0065] 16484.185551, R 2 =0.99996, that is, the gallic acid concentration has good linearity in the range of 5.208-82.334 μg / mL.

[0066] Gentisic acid determination, with the measured peak area as the ordinate and the reference substance concentration (μg / mL) as the abscissa, draw a standard curve and get the regression equation y=5885.958232x+

[0067] 20696.958498, R 2 =0.99991, that is, the linearity of gentisic acid concentration is good in the range of 5.208-82.334 μg / mL.

[0068] Cinnamic acid determination, with the measured peak area as the ordinate and the reference substance concentration (μg / mL) as the abscissa, draw a standard curve and get the regression equation, y=716.992011x-3631.482290, R 2 =0.99992, that is, the cinnamic acid concentration has good linearity in the range of 5.750 to 92.000 μg / mL.

[0069] Isochlorogenic acid C was determined by plotting the standard curve with the peak area as the ordinate and the concentration of the reference substance (μg / mL) as the abscissa, and the regression equation was y=3081.863006x-9242.767901, R 2 =0.99994, that is, the concentration of isochlorogenic acid C is between 5.208 and

[0070] The linearity was good in the range of 82.334 μg / mL.

[0071] Isochlorogenic acid A was determined by plotting the standard curve with the peak area as the ordinate and the concentration of the reference substance (μg / mL) as the abscissa, and the regression equation was y=2517.553092x-11249.155653, R 2 =0.99992, that is, the concentration of isochlorogenic acid A has good linearity in the range of 4.792-76.666 μg / mL.

[0072] For caffeic acid determination, the peak area was used as the ordinate and the concentration of the reference substance (μg / mL) was used as the abscissa to draw a standard curve, and the regression equation was y=1640.233397x+

[0073] 24835.657032, R 2 =0.99991, that is, the caffeic acid concentration has good linearity in the range of 5.208-82.334 μg / mL.

[0074] For salicylic acid determination, the peak area was used as the ordinate and the concentration of the reference substance (μg / mL) was used as the abscissa to draw a standard curve, and the regression equation was y=8.113492x+108.881873.

[0075] R 2 =0.99994768, that is, the salicylic acid concentration has good linearity in the range of 5.625-90 μg / mL.

[0076] Citric acid determination, with the measured peak area as the ordinate and the reference substance concentration (μg / mL) as the abscissa, draw a standard curve and get the regression equation y=3283.394208x-10415.149312, R 2 =0.99990877, that is, the citric acid concentration has good linearity in the range of 5.208-82.334 μg / mL.

[0077] 4.4 Precision test

[0078] The reference solution was accurately aspirated and injected 6 times, 2 μL each time, and the peak area was measured. The RSD of the peak area of ​​each component was <2.0%, indicating that the instrument had good precision. The results are shown in Table 3.

[0079] Table 3 Precision test results

[0080]

[0081] 4.5 Stability test

[0082] The same test solution was taken and measured at 0, 3, 6, 9, 12, and 24 hours after preparation. The results showed that the RSD of the peak area of ​​each component was <2.0%, indicating that the test solution was stable within 24 hours. The results are shown in Table 4.

[0083] Table 4 Stability test results

[0084]

[0085] 4.6 Repeatability test

[0086] Take 6 samples of the same batch number, and operate according to the preparation method under "Preparation of test solution", inject the samples, measure the peak area, and calculate the content. The results are shown in Table 5.

[0087] Table 5 Results of repeatability test

[0088]

[0089]

[0090] 4.7 Recovery test

[0091] Take a sample with a known content, accurately measure 6 portions, 0.5 mL each, place in a 50 mL volumetric flask, and accurately add 0.40 mL of 1.0363 mg / mL malic acid reference solution, 0.80 mL of 1.0218 mg / mL chlorogenic acid reference solution, 0.70 mL of 1.0276 mg / mL gallic acid reference solution, 1.10 mL of 1.0016 mg / mL gentisic acid reference solution, and 1.1061 mg / mL cinnamic acid reference solution. 0.50mL, 1.0848mg / mL isochlorogenic acid C reference solution 0.50mL, 1.1081mg / mL isochlorogenic acid A reference solution 0.50mL, 1.0958mg / mL caffeic acid reference solution 0.90mL, 0.9531mg / mL salicylic acid reference solution 2.30mL, 0.9983mg / mL citric acid reference solution 2.50mL, prepared in the same way as under "Preparation of test solution", and the peak area was determined. The results are shown in Table 6.

[0092] Table 6 Sample recovery test results

[0093]

[0094]

[0095] 4.8 The results of the determination of the contents of 10 ingredients in 10 batches of Qingrejiedu oral liquid are as follows (see Table 7).

[0096] Table 7 Contents of 10 ingredients in 10 batches of Qingrejiedu oral liquid (μg / mL)

[0097]

[0098]

[0099] Embodiment 2:

[0100] UPLC-MS content detection of 10 components in different batches of Qingrejiedu oral liquid from a certain manufacturer

[0101] 1. Preparation of test solution

[0102] Accurately measure 1 mL of Qingrejiedu oral solution from 10 different batches of a certain manufacturer, place it in a 10 mL volumetric flask, dilute to the mark with ultrapure water, shake well, filter, and use as the test solution;

[0103] 2. Preparation of mixed reference solution

[0104] Accurately weigh appropriate amounts of malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, salicylic acid, citric acid, catalpol, and chlorpheniramine reference substances, place them in a 20 mL volumetric flask, add 50% methanol to dissolve and dilute to the mark, and shake well to obtain;

[0105] 3. UPLC chromatographic conditions

[0106] Chromatographic column: ZORBAX RRHD C18 column, 2.1×100 mm, particle size 1.8 μm; 0.1% formic acid water as mobile phase A, methanol as mobile phase B, detection wavelength: 240 nm; flow rate: 0.3 mL / min; column temperature: 20°C; gradient elution according to the following table:

[0107]

[0108]

[0109] 5. Determination method: Accurately pipette 2 μL of reference solution and test solution respectively, inject into ultra-high performance liquid chromatography, and determine according to the chromatographic conditions described in step C. The results of the determination of the contents of 10 ingredients in 10 batches of Qingrejiedu oral liquid are as follows (see Table 8)

[0110] Table 8. Contents of 10 ingredients in different batches of Qingrejiedu oral liquid from a certain manufacturer (ng / μL)

[0111]

[0112]

[0113] Embodiment 3:

[0114] UPLC-MS content detection of 10 components of Qingrejiedu oral liquid from different manufacturers

[0115] A. Preparation of test solution

[0116] Accurately measure 1 mL of Qingrejiedu oral liquid, place it in a 10 mL volumetric flask, dilute to the mark with pure water, shake well, filter, and use as the test solution;

[0117] B. Preparation of mixed reference solution

[0118] Accurately weigh appropriate amounts of malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, salicylic acid, citric acid, catalpol, and chlorpheniramine reference substances, place them in a 20 mL volumetric flask, add 50% methanol to dissolve and dilute to the mark, and shake well to obtain;

[0119] C. UPLC Chromatographic Conditions

[0120] Chromatographic column: ZORBAX RRHD C18 column, 2.1×100 mm, particle size 1.8 μm; 0.1% formic acid water as mobile phase A, methanol as mobile phase B, detection wavelength: 240 nm; flow rate: 0.3 mL / min; column temperature: 20°C; gradient elution according to the following table:

[0121]

[0122] D. Determination method: Accurately pipette 2 μL of reference solution and test solution respectively, inject into ultra-high performance liquid chromatography, and determine according to the chromatographic conditions described in step C.

[0123] Comparative Example 1 Study on the UPLC Determination of 10 Components of Qingrejiedu Oral Liquid

[0124] The 10 components of Qingrejiedu oral liquid were simultaneously determined by UPLC using existing technology. The specific technical scheme is as follows:

[0125] A. Preparation of test solution

[0126] Accurately measure 1 mL of Qingrejiedu oral liquid, place it in a 10 mL volumetric flask, dilute to the mark with ultrapure water, shake well, filter, and use as the test solution;

[0127] B. Preparation of mixed reference solution

[0128] Accurately weigh appropriate amounts of malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, salicylic acid, citric acid, catalpol, and chlorpheniramine reference substances, place them in a 20 mL volumetric flask, add 50% methanol to dissolve and dilute to the mark, and shake well to obtain;

[0129] C. UPLC Chromatographic Conditions

[0130] Chromatographic column: ZORBAX RRHD C18 column, 2.1×100 mm, particle size 1.8 μm; 0.1% formic acid water as mobile phase A, methanol as mobile phase B, detection wavelength: 240 nm; flow rate: 0.3 mL / min; column temperature: 20°C; gradient elution according to the following table:

[0131]

[0132] D. Determination method: Accurately pipette 2 μL of the reference solution and the test solution respectively, inject into HPLC-MS, and determine according to the chromatographic conditions described in step C. The results of the determination of the contents of 10 ingredients in 10 batches of Qingrejiedu oral liquid are as follows (see Table 8)

[0133] Table 8 Contents of 10 ingredients in Qingrejiedu oral solution from 10 different manufacturers (ng / μL)

[0134]

[0135]

[0136] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A method for detecting multiple components of Qingrejiedu oral liquid using UPLC-MS, characterized in that: The method uses ultra-high performance liquid chromatography-mass spectrometry to determine the contents of malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid, and salicylic acid in the preparation; The following steps are involved: S1: Preparation of test solution: accurately measure 1 mL of Qingrejiedu oral solution, place it in a 10 mL volumetric flask, dilute to the mark with pure water, shake well, filter, and use as the test solution; S2: Preparation of reference solution: accurately weigh malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid, and salicylic acid reference substances, place in a volumetric flask, add methanol and pure water to dissolve and dilute to the mark, shake well to obtain; S3: Determine the HPLC-MS conditions: UPLC chromatographic conditions: C18 chromatographic column, 0.1% formic acid aqueous solution as mobile phase A, methanol as mobile phase B, gradient elution; S4: Determination method: Accurately pipette 1.5 mL of reference solution and test solution into injection bottles respectively, place in ultra-high performance liquid chromatography, and determine according to the chromatographic conditions described in S3.

2. The method for detecting multiple components of Qingrejiedu oral liquid by UPLC-MS according to claim 1, characterized in that: In the S2, malic acid, chlorogenic acid, gallic acid, gentisic acid, cinnamic acid, isochlorogenic acid C, isochlorogenic acid A, caffeic acid, citric acid, and salicylic acid reference substances are weighed, placed in a volumetric flask, 50% methanol is added to dissolve and dilute to the scale, and shake well.

3. The method for detecting multiple components of Qingrejiedu oral liquid by UPLC-MS according to claim 2, characterized in that: In the S2, add 50%-90% methanol and pure water in a ratio of 50:50 to dissolve and dilute to the scale, and shake well to obtain.

4. The method for detecting multiple components of Qingrejiedu oral liquid by UPLC-MS according to claim 3, characterized in that: In the S3, the specification of the chromatographic column is 2.1×100 mm, and the particle size is 1.8 μm.

5. The method for detecting multiple components of Qingrejiedu oral liquid by UPLC-MS according to claim 4, characterized in that: In the S3, the detection wavelength is 230-250 nm; the flow rate is 0.2-0.4 mL / min; and the column temperature is 20-40°C.

6. The method for detecting multiple components of Qingrejiedu oral liquid by UPLC-MS according to claim 5, characterized in that: In S3, the gradient elution conditions are:

7. The method for detecting multiple components of Qingrejiedu oral liquid by UPLC-MS according to claim 6, characterized in that: The mass spectrometry conditions of the method are as follows:

8. The method for detecting multiple components of Qingrejiedu oral liquid by UPLC-MS according to claim 7, characterized in that: In the S3, the detection wavelength is 240 nm, the flow rate is 0.3 mL / min, and the column temperature is 20°C.

9. The method for detecting multiple components of Qingrejiedu oral liquid by UPLC-MS according to claim 8, characterized in that: In the S3, Agilent 1290 liquid phase + G6470 tandem mass spectrometer is specifically used.

Citation Information

Patent Citations

  • Detection method of kidney-tonifying essence-replenishing oral liquid

    CN116068119A